Efficacy, Safety, and Tolerability of Selonsertib (GS-4997) in Participants With Diabetic Kidney Disease

NCT02177786 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

334

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Kidney Disease

Interventions

DRUG: Selonsertib
DRUG: Placebo to match selonsertib

Sponsor

Gilead Sciences